Literature DB >> 3301693

Tumorigenicity of T24 urinary bladder carcinoma cell sublines.

U Flatow, A B Rabson, A S Rabson.   

Abstract

Two sublines of the T24 human urinary bladder carcinoma cell line which differ in tumorigenicity in nude mice have been studied (T24A and T24P). T24A obtained directly from the American Type Culture Collection is non-tumorigenic while T24P obtained after multiple passages in several NCI laboratories produces tumors in 100% of inoculated mice. T24P cells differ morphologically from T24A, have a higher saturation density, are less serum-dependent for growth, and are more sensitive to ouabain toxicity. Cytogenetic studies show that the 2 sublines differ significantly in chromosome number, with a modal chromosome range of 76-89 in T24A and a modal chromosome number of 48-51 in T24P. Southern blot analysis of MspI cleaved T24A and T24P DNAs with the H-ras SmaI probe indicates that both contain only the activated mutant allele originally described in T24. Northern blot analysis shows equal amounts of the 1.2kB ras polyadenylated message, and immunoblotting with rasHa antibody demonstrates no significant difference in the amounts of ras proteins. These results indicate that 2 sublines of a ras oncogene-containing tumor cell line can differ greatly in tumorigenicity and other in vitro characteristics of transformation, and yet have similar expression of the ras oncogene. The fact that the tumorigenic cell line contains fewer chromosomes suggests that tumorigenicity may be related to the loss of some regulatory gene.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3301693     DOI: 10.1002/ijc.2910400220

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  6 in total

1.  Phenotypic characterization of human umbilical vein endothelial (ECV304) and urinary carcinoma (T24) cells: endothelial versus epithelial features.

Authors:  K Suda; B Rothen-Rutishauser; M Günthert; H Wunderli-Allenspach
Journal:  In Vitro Cell Dev Biol Anim       Date:  2001-09       Impact factor: 2.416

2.  Recombinant human interferon gamma exerts an anti-proliferative effect and modulates the expression of human leukocyte antigens A,B,C and DR in human urothelial cell lines.

Authors:  S S Ottesen; V Ahrenkiel; J Kieler
Journal:  Cancer Immunol Immunother       Date:  1990       Impact factor: 6.968

3.  Upregulated MT1-MMP/TIMP-2 axis in the TSU-Pr1-B1/B2 model of metastatic progression in transitional cell carcinoma of the bladder.

Authors:  Christine L Chaffer; Bonnie Dopheide; Daniel R McCulloch; Allan B Lee; Jane M Moseley; Erik W Thompson; Elizabeth D Williams
Journal:  Clin Exp Metastasis       Date:  2005       Impact factor: 5.150

4.  The evolution of single cell-derived colorectal cancer cell lines is dominated by the continued selection of tumor-specific genomic imbalances, despite random chromosomal instability.

Authors:  Darawalee Wangsa; Rüdiger Braun; Madison Schiefer; Edward Michael Gertz; Daniel Bronder; Isabel Quintanilla; Hesed M Padilla-Nash; Irianna Torres; Cynthia Hunn; Lidia Warner; Floryne O Buishand; Yue Hu; Daniela Hirsch; Timo Gaiser; Jordi Camps; Russell Schwartz; Alejandro A Schäffer; Kerstin Heselmeyer-Haddad; Thomas Ried
Journal:  Carcinogenesis       Date:  2018-07-30       Impact factor: 4.944

5.  T24 human bladder carcinoma cells with activated Ha-ras protooncogene: nontumorigenic cells susceptible to malignant transformation with carcinogen.

Authors:  D R Senger; C A Perruzzi; I U Ali
Journal:  Proc Natl Acad Sci U S A       Date:  1988-07       Impact factor: 11.205

6.  Clonal analysis of a bladder cancer cell line: an experimental model of tumour heterogeneity.

Authors:  J L Brown; P J Russell; J Philips; J Wotherspoon; D Raghavan
Journal:  Br J Cancer       Date:  1990-03       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.